Exact Mass: 1126.412474

Exact Mass Matches: 1126.412474

Found 22 metabolites which its exact mass value is equals to given mass value 1126.412474, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

UK 63598

N,N-[(1S,1R,2S,2S,8R,11S,14R,17S,21R,24S,27R)-2,2,3,11,13,16,24,26-octamethyl-27-(methylsulfanyl)-2,5,9,12,15,18,22,25-octaoxo-6,19-dioxa-28-thia-3,10,13,16,23,26-hexaazadispiro[cyclopropane-1,4-bicyclo[12.12.3]nonacosane-17,1-cyclopropane]-8,21-diyl]bis(3-hydroxyquinoline-2-carboxamide)

C53H62N10O14S2 (1126.3888192)


A cyclodepsipeptide antibiotic that is isolated from Streptomyces sp. SNA15896 and also exhibits antitumour activity.

   

PIP3(18:1(11Z)/20:3(5Z,8Z,11Z))

{[(3s,5S)-2,4-dihydroxy-3-({hydroxy[(2R)-2-[(5Z,8Z,11Z)-icosa-5,8,11-trienoyloxy]-3-[(11Z)-octadec-11-enoyloxy]propoxy]phosphoryl}oxy)-5,6-bis(phosphonooxy)cyclohexyl]oxy}phosphonic acid

C47H86O22P4 (1126.4560976)


PIP3(18:1(11Z)/20:3(5Z,8Z,11Z)) is a phosphatidylinositol trisphosphate. Phosphatidylinositol trisphosphates are acidic (anionic) phospholipids that consist of a phosphatidic acid backbone, linked via the phosphate group to a trisphosphorylated inositol (hexahydroxycyclohexane). Phosphatidylinositol trisphosphates are generated from phosphatidylinositols, which are phosphorylated by a number of different kinases that place the phosphate moiety on positions 4 and 5 of the inositol ring, although position 3 can also be phosphorylated. Phosphatidylinositols trisphosphates can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 18 and 20 carbons are the most common. PIP3(18:1(11Z)/20:3(5Z,8Z,11Z)), in particular, consists of one chain of vaccenic acid at the C-1 position and one chain of mead acid at the C-2 position. The vaccenic acid moiety is derived from butter fat and animal fat, while the mead acid moiety is derived from fish oils, liver and kidney. The most important phosphatidylinositol trisphosphate in both quantitative and biological terms is phosphatidylinositol 3,4,5-triphosphate. Phosphatidylinositol and the phosphatidylinositol phosphates are the main source of diacylglycerols that serve as signalling molecules, via the action of phospholipase C enzymes. Phosphatidylinositols phosphates are usually present at low levels only in tissues, typically at about 1 to 3\\% of the concentration of phosphatidylinositol. [HMDB] PIP3(18:1(11Z)/20:3(5Z,8Z,11Z)) is a phosphatidylinositol trisphosphate. Phosphatidylinositol trisphosphates are acidic (anionic) phospholipids that consist of a phosphatidic acid backbone, linked via the phosphate group to a trisphosphorylated inositol (hexahydroxycyclohexane). Phosphatidylinositol trisphosphates are generated from phosphatidylinositols, which are phosphorylated by a number of different kinases that place the phosphate moiety on positions 4 and 5 of the inositol ring, although position 3 can also be phosphorylated. Phosphatidylinositols trisphosphates can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 18 and 20 carbons are the most common. PIP3(18:1(11Z)/20:3(5Z,8Z,11Z)), in particular, consists of one chain of vaccenic acid at the C-1 position and one chain of mead acid at the C-2 position. The vaccenic acid moiety is derived from butter fat and animal fat, while the mead acid moiety is derived from fish oils, liver and kidney. The most important phosphatidylinositol trisphosphate in both quantitative and biological terms is phosphatidylinositol 3,4,5-triphosphate. Phosphatidylinositol and the phosphatidylinositol phosphates are the main source of diacylglycerols that serve as signalling molecules, via the action of phospholipase C enzymes. Phosphatidylinositols phosphates are usually present at low levels only in tissues, typically at about 1 to 3\\% of the concentration of phosphatidylinositol.

   

PIP3(18:1(11Z)/20:3(8Z,11Z,14Z))

{[(3s,5S)-2,4-dihydroxy-3-({hydroxy[(2R)-2-[(8Z,11Z,14Z)-icosa-8,11,14-trienoyloxy]-3-[(11Z)-octadec-11-enoyloxy]propoxy]phosphoryl}oxy)-5,6-bis(phosphonooxy)cyclohexyl]oxy}phosphonic acid

C47H86O22P4 (1126.4560976)


PIP3(18:1(11Z)/20:3(8Z,11Z,14Z)) is a phosphatidylinositol trisphosphate. Phosphatidylinositol trisphosphates are acidic (anionic) phospholipids that consist of a phosphatidic acid backbone, linked via the phosphate group to a trisphosphorylated inositol (hexahydroxycyclohexane). Phosphatidylinositol trisphosphates are generated from phosphatidylinositols, which are phosphorylated by a number of different kinases that place the phosphate moiety on positions 4 and 5 of the inositol ring, although position 3 can also be phosphorylated. Phosphatidylinositols trisphosphates can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 18 and 20 carbons are the most common. PIP3(18:1(11Z)/20:3(8Z,11Z,14Z)), in particular, consists of one chain of vaccenic acid at the C-1 position and one chain of homo-g-linolenic acid at the C-2 position. The vaccenic acid moiety is derived from butter fat and animal fat, while the homo-g-linolenic acid moiety is derived from fish oils, liver and kidney. The most important phosphatidylinositol trisphosphate in both quantitative and biological terms is phosphatidylinositol 3,4,5-triphosphate. Phosphatidylinositol and the phosphatidylinositol phosphates are the main source of diacylglycerols that serve as signalling molecules, via the action of phospholipase C enzymes. Phosphatidylinositols phosphates are usually present at low levels only in tissues, typically at about 1 to 3\\% of the concentration of phosphatidylinositol. [HMDB] PIP3(18:1(11Z)/20:3(8Z,11Z,14Z)) is a phosphatidylinositol trisphosphate. Phosphatidylinositol trisphosphates are acidic (anionic) phospholipids that consist of a phosphatidic acid backbone, linked via the phosphate group to a trisphosphorylated inositol (hexahydroxycyclohexane). Phosphatidylinositol trisphosphates are generated from phosphatidylinositols, which are phosphorylated by a number of different kinases that place the phosphate moiety on positions 4 and 5 of the inositol ring, although position 3 can also be phosphorylated. Phosphatidylinositols trisphosphates can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 18 and 20 carbons are the most common. PIP3(18:1(11Z)/20:3(8Z,11Z,14Z)), in particular, consists of one chain of vaccenic acid at the C-1 position and one chain of homo-g-linolenic acid at the C-2 position. The vaccenic acid moiety is derived from butter fat and animal fat, while the homo-g-linolenic acid moiety is derived from fish oils, liver and kidney. The most important phosphatidylinositol trisphosphate in both quantitative and biological terms is phosphatidylinositol 3,4,5-triphosphate. Phosphatidylinositol and the phosphatidylinositol phosphates are the main source of diacylglycerols that serve as signalling molecules, via the action of phospholipase C enzymes. Phosphatidylinositols phosphates are usually present at low levels only in tissues, typically at about 1 to 3\\% of the concentration of phosphatidylinositol.

   

PIP3(18:1(9Z)/20:3(5Z,8Z,11Z))

{[(3s,5S)-2,4-dihydroxy-3-({hydroxy[(2R)-2-[(5Z,8Z,11Z)-icosa-5,8,11-trienoyloxy]-3-[(9Z)-octadec-9-enoyloxy]propoxy]phosphoryl}oxy)-5,6-bis(phosphonooxy)cyclohexyl]oxy}phosphonic acid

C47H86O22P4 (1126.4560976)


PIP3(18:1(9Z)/20:3(5Z,8Z,11Z)) is a phosphatidylinositol trisphosphate. Phosphatidylinositol trisphosphates are acidic (anionic) phospholipids that consist of a phosphatidic acid backbone, linked via the phosphate group to a trisphosphorylated inositol (hexahydroxycyclohexane). Phosphatidylinositol trisphosphates are generated from phosphatidylinositols, which are phosphorylated by a number of different kinases that place the phosphate moiety on positions 4 and 5 of the inositol ring, although position 3 can also be phosphorylated. Phosphatidylinositols trisphosphates can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 18 and 20 carbons are the most common. PIP3(18:1(9Z)/20:3(5Z,8Z,11Z)), in particular, consists of one chain of oleic acid at the C-1 position and one chain of mead acid at the C-2 position. The oleic acid moiety is derived from vegetable oils, especially olive and canola oil, while the mead acid moiety is derived from fish oils, liver and kidney. The most important phosphatidylinositol trisphosphate in both quantitative and biological terms is phosphatidylinositol 3,4,5-triphosphate. Phosphatidylinositol and the phosphatidylinositol phosphates are the main source of diacylglycerols that serve as signalling molecules, via the action of phospholipase C enzymes. Phosphatidylinositols phosphates are usually present at low levels only in tissues, typically at about 1 to 3\\% of the concentration of phosphatidylinositol. [HMDB] PIP3(18:1(9Z)/20:3(5Z,8Z,11Z)) is a phosphatidylinositol trisphosphate. Phosphatidylinositol trisphosphates are acidic (anionic) phospholipids that consist of a phosphatidic acid backbone, linked via the phosphate group to a trisphosphorylated inositol (hexahydroxycyclohexane). Phosphatidylinositol trisphosphates are generated from phosphatidylinositols, which are phosphorylated by a number of different kinases that place the phosphate moiety on positions 4 and 5 of the inositol ring, although position 3 can also be phosphorylated. Phosphatidylinositols trisphosphates can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 18 and 20 carbons are the most common. PIP3(18:1(9Z)/20:3(5Z,8Z,11Z)), in particular, consists of one chain of oleic acid at the C-1 position and one chain of mead acid at the C-2 position. The oleic acid moiety is derived from vegetable oils, especially olive and canola oil, while the mead acid moiety is derived from fish oils, liver and kidney. The most important phosphatidylinositol trisphosphate in both quantitative and biological terms is phosphatidylinositol 3,4,5-triphosphate. Phosphatidylinositol and the phosphatidylinositol phosphates are the main source of diacylglycerols that serve as signalling molecules, via the action of phospholipase C enzymes. Phosphatidylinositols phosphates are usually present at low levels only in tissues, typically at about 1 to 3\\% of the concentration of phosphatidylinositol.

   

PIP3(18:1(9Z)/20:3(8Z,11Z,14Z))

{[(3s,5S)-2,4-dihydroxy-3-({hydroxy[(2R)-2-[(8Z,11Z,14Z)-icosa-8,11,14-trienoyloxy]-3-[(9Z)-octadec-9-enoyloxy]propoxy]phosphoryl}oxy)-5,6-bis(phosphonooxy)cyclohexyl]oxy}phosphonic acid

C47H86O22P4 (1126.4560976)


PIP3(18:1(9Z)/20:3(8Z,11Z,14Z)) is a phosphatidylinositol trisphosphate. Phosphatidylinositol trisphosphates are acidic (anionic) phospholipids that consist of a phosphatidic acid backbone, linked via the phosphate group to a trisphosphorylated inositol (hexahydroxycyclohexane). Phosphatidylinositol trisphosphates are generated from phosphatidylinositols, which are phosphorylated by a number of different kinases that place the phosphate moiety on positions 4 and 5 of the inositol ring, although position 3 can also be phosphorylated. Phosphatidylinositols trisphosphates can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 18 and 20 carbons are the most common. PIP3(18:1(9Z)/20:3(8Z,11Z,14Z)), in particular, consists of one chain of oleic acid at the C-1 position and one chain of homo-g-linolenic acid at the C-2 position. The oleic acid moiety is derived from vegetable oils, especially olive and canola oil, while the homo-g-linolenic acid moiety is derived from fish oils, liver and kidney. The most important phosphatidylinositol trisphosphate in both quantitative and biological terms is phosphatidylinositol 3,4,5-triphosphate. Phosphatidylinositol and the phosphatidylinositol phosphates are the main source of diacylglycerols that serve as signalling molecules, via the action of phospholipase C enzymes. Phosphatidylinositols phosphates are usually present at low levels only in tissues, typically at about 1 to 3\\% of the concentration of phosphatidylinositol. [HMDB] PIP3(18:1(9Z)/20:3(8Z,11Z,14Z)) is a phosphatidylinositol trisphosphate. Phosphatidylinositol trisphosphates are acidic (anionic) phospholipids that consist of a phosphatidic acid backbone, linked via the phosphate group to a trisphosphorylated inositol (hexahydroxycyclohexane). Phosphatidylinositol trisphosphates are generated from phosphatidylinositols, which are phosphorylated by a number of different kinases that place the phosphate moiety on positions 4 and 5 of the inositol ring, although position 3 can also be phosphorylated. Phosphatidylinositols trisphosphates can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 18 and 20 carbons are the most common. PIP3(18:1(9Z)/20:3(8Z,11Z,14Z)), in particular, consists of one chain of oleic acid at the C-1 position and one chain of homo-g-linolenic acid at the C-2 position. The oleic acid moiety is derived from vegetable oils, especially olive and canola oil, while the homo-g-linolenic acid moiety is derived from fish oils, liver and kidney. The most important phosphatidylinositol trisphosphate in both quantitative and biological terms is phosphatidylinositol 3,4,5-triphosphate. Phosphatidylinositol and the phosphatidylinositol phosphates are the main source of diacylglycerols that serve as signalling molecules, via the action of phospholipase C enzymes. Phosphatidylinositols phosphates are usually present at low levels only in tissues, typically at about 1 to 3\\% of the concentration of phosphatidylinositol.

   

Nicotinic acid 14-acetoxy-21-(2-acetoxy-2-methylpropionyloxy)-13-(benzoyloxy)-5,7,8,9,10,12,13,14,15,17,18,19-dodecahydro-10,20-dihydroxy-8,18,19,20-tetramethyl-5,17-dioxo-22-(3,4,5-trimethoxybenzoyloxy)-8,11-epoxy-9,12-ethano-11,15-methano-11H-[1,8]dioxacycloheptadecino[4,3-b]pyridine-12-ylmethyl ester

Nicotinic acid 14-acetoxy-21-(2-acetoxy-2-methylpropionyloxy)-13-(benzoyloxy)-5,7,8,9,10,12,13,14,15,17,18,19-dodecahydro-10,20-dihydroxy-8,18,19,20-tetramethyl-5,17-dioxo-22-(3,4,5-trimethoxybenzoyloxy)-8,11-epoxy-9,12-ethano-11,15-methano-11H-[1,8]dioxacycloheptadecino[4,3-b]pyridine-12-ylmethyl ester

C57H62N2O22 (1126.3794032)


   
   

PIP3(38:4)

1-(11Z-Octadecenoyl)-2-(8Z,11Z,14Z-eicosatrienoyl)-sn-glycero-3-phospho-(1-myo-inositol-3,4,5-trisphosphate)

C47H86O22P4 (1126.4560976)


   

PtdIns-(3,4,5)-P3 (1-stearoyl, 2-arachidonoyl)

1-(1-octadecanoyl-2R-(5Z,8Z,11Z,14Z)-eicosatetraenoylphosphatidyl)inositol-3,4,5-trisphosphate, tetrasodium salt

C47H86O22P4 (1126.4560976)


   

ENDO-3 7 14-TRIS(DIMETHYLVINYLSILYLOXY)&

ENDO-3 7 14-TRIS(DIMETHYLVINYLSILYLOXY)&

C47H90O12Si10 (1126.412474)


   

N,N-[(1S,1R,2S,2S,8R,11S,14R,17S,21R,24S,27R)-2,2,3,11,13,16,24,26-octamethyl-27-(methylsulfanyl)-2,5,9,12,15,18,22,25-octaoxo-6,19-dioxa-28-thia-3,10,13,16,23,26-hexaazadispiro[cyclopropane-1,4-bicyclo[12.12.3]nonacosane-17,1-cyclopropane]-8,21-diyl]bis(3-hydroxyquinoline-2-carboxamide)

N,N-[(1S,1R,2S,2S,8R,11S,14R,17S,21R,24S,27R)-2,2,3,11,13,16,24,26-octamethyl-27-(methylsulfanyl)-2,5,9,12,15,18,22,25-octaoxo-6,19-dioxa-28-thia-3,10,13,16,23,26-hexaazadispiro[cyclopropane-1,4-bicyclo[12.12.3]nonacosane-17,1-cyclopropane]-8,21-diyl]bis(3-hydroxyquinoline-2-carboxamide)

C53H62N10O14S2 (1126.3888192)


   

PIP3(18:1(11Z)/20:3(5Z,8Z,11Z))

PIP3(18:1(11Z)/20:3(5Z,8Z,11Z))

C47H86O22P4 (1126.4560976)


   

PIP3(18:1(11Z)/20:3(8Z,11Z,14Z))

PIP3(18:1(11Z)/20:3(8Z,11Z,14Z))

C47H86O22P4 (1126.4560976)


   

PIP3(18:1(9Z)/20:3(5Z,8Z,11Z))

PIP3(18:1(9Z)/20:3(5Z,8Z,11Z))

C47H86O22P4 (1126.4560976)


   

PIP3(18:1(9Z)/20:3(8Z,11Z,14Z))

PIP3(18:1(9Z)/20:3(8Z,11Z,14Z))

C47H86O22P4 (1126.4560976)


   

1-stearoyl-2-arachidonoyl-sn-glycero-3-phospho-(1D-myo-inositol 3,4,5-triphosphate)

1-stearoyl-2-arachidonoyl-sn-glycero-3-phospho-(1D-myo-inositol 3,4,5-triphosphate)

C47H86O22P4 (1126.4560976)


A 1-phosphatidyl-1D-myo-inositol 3,4,5-trisphosphate in which the phosphatidyl acyl groups at positions 1 and 2 are specified as stearoyl and arachidonoyl respectively.

   
   
   

n-[(1s,1'r,2s,2''s,4's,8'r,11's,14'r,21'r,24's,29'r)-9',22'-dihydroxy-21'-(3-hydroxyquinoline-2-amido)-2,2'',3',11',13',16',24',26'-octamethyl-29'-(methylsulfanyl)-2',5',12',15',18',25'-hexaoxodispiro[cyclopropane-1,17'-[6,19]dioxa-[28]thia-[3,10,13,16,23,26]hexaazabicyclo[12.12.3]nonacosane-4',1''-cyclopropane]-9',22'-dien-8'-yl]-3-hydroxyquinoline-2-carboxamide

n-[(1s,1'r,2s,2''s,4's,8'r,11's,14'r,21'r,24's,29'r)-9',22'-dihydroxy-21'-(3-hydroxyquinoline-2-amido)-2,2'',3',11',13',16',24',26'-octamethyl-29'-(methylsulfanyl)-2',5',12',15',18',25'-hexaoxodispiro[cyclopropane-1,17'-[6,19]dioxa-[28]thia-[3,10,13,16,23,26]hexaazabicyclo[12.12.3]nonacosane-4',1''-cyclopropane]-9',22'-dien-8'-yl]-3-hydroxyquinoline-2-carboxamide

C53H62N10O14S2 (1126.3888192)


   

n-[(1s,1's,2s,2''s,4'r,8's,11's,14's,21'r,24's,29'r)-9',22'-dihydroxy-21'-(3-hydroxyquinoline-2-amido)-2,2'',3',11',13',16',24',26'-octamethyl-29'-(methylsulfanyl)-2',5',12',15',18',25'-hexaoxodispiro[cyclopropane-1,17'-[6,19]dioxa-[28]thia-[3,10,13,16,23,26]hexaazabicyclo[12.12.3]nonacosane-4',1''-cyclopropane]-9',22'-dien-8'-yl]-3-hydroxyquinoline-2-carboxamide

n-[(1s,1's,2s,2''s,4'r,8's,11's,14's,21'r,24's,29'r)-9',22'-dihydroxy-21'-(3-hydroxyquinoline-2-amido)-2,2'',3',11',13',16',24',26'-octamethyl-29'-(methylsulfanyl)-2',5',12',15',18',25'-hexaoxodispiro[cyclopropane-1,17'-[6,19]dioxa-[28]thia-[3,10,13,16,23,26]hexaazabicyclo[12.12.3]nonacosane-4',1''-cyclopropane]-9',22'-dien-8'-yl]-3-hydroxyquinoline-2-carboxamide

C53H62N10O14S2 (1126.3888192)


   

n-[9',22'-dihydroxy-21'-(3-hydroxyquinoline-2-amido)-2,2'',3',11',13',16',24',26'-octamethyl-29'-(methylsulfanyl)-2',5',12',15',18',25'-hexaoxodispiro[cyclopropane-1,4'-[6,19]dioxa-[28]thia-[3,10,13,16,23,26]hexaazabicyclo[12.12.3]nonacosane-17',1''-cyclopropane]-9',22'-dien-8'-yl]-3-hydroxyquinoline-2-carboxamide

n-[9',22'-dihydroxy-21'-(3-hydroxyquinoline-2-amido)-2,2'',3',11',13',16',24',26'-octamethyl-29'-(methylsulfanyl)-2',5',12',15',18',25'-hexaoxodispiro[cyclopropane-1,4'-[6,19]dioxa-[28]thia-[3,10,13,16,23,26]hexaazabicyclo[12.12.3]nonacosane-17',1''-cyclopropane]-9',22'-dien-8'-yl]-3-hydroxyquinoline-2-carboxamide

C53H62N10O14S2 (1126.3888192)


   

[(1s,3r,13r,14r,17s,18s,19r,20r,21s,22s,23s,24r,25s)-18-(acetyloxy)-21-{[2-(acetyloxy)-2-methylpropanoyl]oxy}-19-(benzoyloxy)-24,25-dihydroxy-3,13,14,25-tetramethyl-6,15-dioxo-22-(3,4,5-trimethoxybenzoyloxy)-2,5,16-trioxa-11-azapentacyclo[15.7.1.0¹,²⁰.0³,²³.0⁷,¹²]pentacosa-7,9,11-trien-20-yl]methyl pyridine-3-carboxylate

[(1s,3r,13r,14r,17s,18s,19r,20r,21s,22s,23s,24r,25s)-18-(acetyloxy)-21-{[2-(acetyloxy)-2-methylpropanoyl]oxy}-19-(benzoyloxy)-24,25-dihydroxy-3,13,14,25-tetramethyl-6,15-dioxo-22-(3,4,5-trimethoxybenzoyloxy)-2,5,16-trioxa-11-azapentacyclo[15.7.1.0¹,²⁰.0³,²³.0⁷,¹²]pentacosa-7,9,11-trien-20-yl]methyl pyridine-3-carboxylate

C57H62N2O22 (1126.3794032)